Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma

Annals of Internal Medicine

Volumn 129, Issue 8, 1998, Pages 622-627

  Taylor, Terry ^a   Specker, Bonny ^b   Robbins, Jacob ^c   Sperling, Matthew ^d   Ho, Mona ^d   Ain, Kenneth ^e   Bigos, S Thomas ^f   Brierley, Jim ^g   Cooper, David ^h   Haugen, Bryan ⁱ   Hay, Ian ^j   Hertzberg, Vicki ^k   Klein, Irwin ^l   Klein, Herbert ^m   Ladenson, Paul ⁿ   Nishiyama, Ronald ^f   Ross, Douglas ^o   Sherman, Steven ^p   Maxon, Harry R ^d  

^a BAYER CORPORATION   (United States)

^b SOUTH DAKOTA STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^e UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^f MAINE MEDICAL CENTER   (United States)

^g PRINCESS MARGARET HOSPITAL   (Canada)

^h SINAI HOSPITAL OF BALTIMORE   (United States)

ⁱ UNIVERSITY OF COLORADO   (United States)

^j MAYO CLINIC   (United States)

^k EMORY UNIVERSITY   (United States)

^l NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^m PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

ⁿ JOHNS HOPKINS HOSPITAL   (United States)

^o MASSACHUSETTS GENERAL HOSPITAL   (United States)

^p UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; THYROID FOLLICULAR CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 15644367081     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-8-199810150-00007     Document Type: Article

References (25)

1. Robbins J, Merino MJ, Boice JD Jr, Ron E, Ain KB, Alexander HR, et al. Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med. 1991;115:133-47.
2. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418-28.
3. Hoie J, Stenwig AE, Kullmann G, Lindegaard M. Distant metastases in papillary thyroid cancer. A review of 91 patients. Cancer. 1988;61:1-6.
4. Pasieka JL, Rotstein LE. Consensus conference on well-differentiated thyroid cancer: a summary. Can J Surg. 1993;36:298-301.
5. Grant CS, Hay ID, Gough IR, Bergstralh EJ, Goellner JR, McConahey WM. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery. 1988;104:954-62.
6. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 1985;55:805-28.
7. DeGroot LJ, Kaplan EL. Second operations for "completion" of thyroidectomy in treatment of differentiated thyroid cancer. Surgery. 1991;110:936-9.
8. Demeure MJ, Clark OH. Surgery in the treatment of thyroid cancer. Endocrinol Metab Clin North America. 1990;19:663-83.
9. Jatzko GR, Lisborg PH, Muller MG, Wette VM. Recurrent nerve palsy after thyroid operations-principal nerve identification and literature review. Surgery. 1994;115:139-44.
10. Sessions RB, Davidson BJ. Thyroid cancer. Med Clin North Am. 1995;77: 517-38.
11. DeGroot U, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414-24.
12. Wong JB, Kaplan MM, Meyer KB, Pauker SG. Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective. Endocrinol Metab Clin North Am. 1990;19:741-59.
13. Maxon HR 3d, Smith HS. Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am. 1990;19:685-718.
14. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med. 1981; 70:511-8.
15. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, et al. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75:714-20.
16. Benker G, Olbricht T, Reinwein D, Reiners C, Sauerwein W, Krause U, et al. Survival rates in patients with differentiated thyroid carcinoma: influence of postoperative external radiotherapy. Cancer. 1990;65:1517-20.
17. Jensen MH, Davis RK, Derrick L. Thyroid cancer: a computer-assisted review of 5287 cases. Otolaryngol Head Neck Surg. 1990;102:51-65.
18. Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys. 1988;14:1063-75.
19. Tubiana M, Haddad E, Schlumberger M, Hill C, Rougier P, Sarrazin D. External radiotherapy in thyroid cancers. Cancer. 1985;55(9 Suppl):2062-71.
20. Rossi RL, Cady B, Silverman ML, Wool MS, ReMine SG, Hodge MB, et al. Surgically incurable well-differentiated thyroid cancer. Prognostic factors and results of therapy. Arch Surg. 1988;123:569-74.
21. Vickery AL Jr, Wang CA, Walker AM. Treatment of intrathyroidal papillary carcinoma of the thyroid. Cancer. 1987;60:2587-95.
22. Martensson H, Terins J. Recurrent laryngeal nerve palsy in thyroid gland surgery related to operations and nerves at risk. Arch Surg. 1985;120:475-7.
23. Staunton MD, Greening WP. Treatment of thyroid cancer in 293 patients. Br J Surg. 1976;63:253-8.
24. Mazzaferri EL. Treating differentiated thyroid carcinoma: where do we draw the line? Mayo Clin Proc. 1991;66:105-11.
25. Farahati J, Reiners C, Stuschke M, Muller SP, Stuben G, Sauerwein W, et al. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer. 1996;77: 172-80.